Analyst Discounts Chances For OHR Pharmaceutical Eye Drug
March 27, 2015 at 14:02 PM EDT
OHR Pharmaceutical Inc (NASDAQ: OHRP) shares plunged Friday after its lead product for eye disease failed to meet the end-point of a ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.